Kamada Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
KMDA
IL0010941198
Pharmaceuticals
| Market Cap | 1.24B 414M 362M 334M 307M 582M 39.85B 592M 3.99B 1.56B 19.48B 1.56B 1.52B 67.14B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.24B 414M 362M 334M 307M 582M 39.85B 592M 3.99B 1.56B 19.48B 1.56B 1.52B 67.14B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 1.93x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | +3.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 57 | 01/07/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 55 | 31/12/2017 |
Eran Nir
COO | Chief Operating Officer | 53 | 01/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 64 | 24/12/2019 |
Leon Recanati
CHM | Chairman | 77 | 07/03/2013 |
David Tsur
BRD | Director/Board Member | 75 | 13/12/1990 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.07% | +4.32% | - | - | 419M | |
| +1.27% | +0.24% | +21.26% | -7.53% | 66.75B | |
| +1.38% | -5.23% | +38.08% | +197.15% | 50.65B | |
| +1.10% | +38.30% | +38.30% | +38.30% | 42.55B | |
| +0.80% | -2.25% | -50.41% | -52.59% | 41.15B | |
| +2.76% | -1.56% | +54.70% | -29.29% | 28.34B | |
| +1.25% | -7.48% | +116.21% | -43.73% | 26.76B | |
| +0.18% | -1.85% | +68.63% | +86.35% | 22.95B | |
| -2.27% | +9.73% | +9.92% | +200.79% | 20B | |
| -1.70% | +5.53% | +76.00% | +353.68% | 16.48B | |
| Average | +0.77% | -0.22% | +41.41% | +82.57% | 35.07B | |
| Weighted average by Cap. | +0.87% | -0.65% | +33.55% | +59.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 585M 195M 171M 157M 145M 274M 18.78B 279M 1.88B 737M 9.18B 733M 717M 31.64B | 642M 214M 187M 173M 159M 301M 20.62B 306M 2.06B 809M 10.08B 805M 787M 34.73B |
| Net income | 72.01M 24.04M 21.02M 19.39M 17.82M 33.77M 2.31B 34.34M 231M 90.81M 1.13B 90.27M 88.29M 3.9B | 104M 34.59M 30.25M 27.9M 25.65M 48.6M 3.33B 49.43M 333M 131M 1.63B 130M 127M 5.61B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
